Cystic fibrosis: desensitization in delayed hypersensitivity reactions to elexacaftor/tezacaftor/ivacaftor

Background: Cystic fibrosis transmembrane conductance regulator modulators are the only available treatment for cystic fibrosis. Although elexacaftor/tezacaftor/ivacaftor (ELX/TEZ/IVA) is well-tolerated, rash has been reported as very frequent. In severe rashes, ELX/TEZ/IVA withdrawal is necessary,...

وصف كامل

التفاصيل البيبلوغرافية

الحاوية / القاعدة:	Frontiers in Pharmacology
المؤلفون الرئيسيون:	L. Gómez-Ganda, P. Galván-Blasco, A. Fernández-Polo, V. Cardona, B. García-Palop, CJ Parramón-Teixidó, E. Polverino, A. Álvarez-Fernández
التنسيق:	مقال
اللغة:	الإنجليزية
منشور في:	Frontiers Media S.A. 2024-06-01
الموضوعات:	cystic fibrosis cystic fibrosis transmembrane conductance regulator modulator delayed hypersensitivity desensitization elexacaftor/tezacaftor/ivacaftor rash
الوصول للمادة أونلاين:	https://www.frontiersin.org/articles/10.3389/fphar.2024.1392986/full